What development phase is 2,2'-DITHIODIETHANESULFONIC ACID in?

2,2'-DITHIODIETHANESULFONIC ACID is in Phase 3.

Last reviewed 2026-04-20 · How we verify

2,2'-DITHIODIETHANESULFONIC ACID

Phase 3 active Small molecule Quality 0/100

At a glance

Generic name	2,2'-DITHIODIETHANESULFONIC ACID
Modality	Small molecule
Phase	Phase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma (PHASE2)
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel (PHASE3)
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

2,2'-DITHIODIETHANESULFONIC ACID CI brief — competitive landscape report
2,2'-DITHIODIETHANESULFONIC ACID updates RSS · CI watch RSS